IM Cannabis Q4 GAAP EPS $(0.23) Beats $(0.39) Estimate, Sales $9.54M Miss $10.43M Estimate

IM Cannabis (NASDAQ:IMCC) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.39) by 41.03 percent. This is a 78.7 percent increase over losses of $(1.08) per share from the same period last year. The company reported quarterly sales of $9.54 million which missed the analyst consensus estimate of $10.43 million by 8.58 percent. This is a 21.28 percent increase over sales of $7.86 million the same period last year.